The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/ FUS::ERG [0.03%]
携带t(16;21)(p11;q22)/FUS::ERG的罕见急性髓系白血病患者中RTK-RAS信号通路富集
Anli Lai,Wenbing Liu,Hui Wei et al.
Anli Lai et al.
Acute myeloid leukemia (AML) with t(16;21)(p11;q22)/FUS::ERG is a rare AML subtype associated with poor prognosis. However, its clinical and molecular features remain poorly defined. We determined the clinicopathological, genomic, and trans...
Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow [0.03%]
成人小鼠骨髓中的早期巨核细胞系谱 committed 祖细胞
Zixian Liu,Jinhong Wang,Yao Ma et al.
Zixian Liu et al.
Hematopoietic stem cells (HSCs) have been considered to progressively lose their self-renewal and differentiation potentials prior to the commitment to each blood lineage. However, recent studies have suggested that megakaryocyte progenitor...
Investigation of the relationship between coagulation parameters and mortality in COVID-19 infection [0.03%]
凝血参数与COVID-19感染患者死亡率关系的调查研究
Fatih Ikiz,Ahmet Ak
Fatih Ikiz
This study, which included patients over the age of 18 who were diagnosed with coronavirus disease 2019 (COVID-19) in the emergency clinic, aims to determine the relationship between coagulation parameters and mortality. Epidemiologic data ...
The elevation of red blood cell distribution width is an independent prognostic factor for juvenile myelomonocytic leukemia [0.03%]
红细胞分布宽度升高是儿童单核细胞增多性白血病的独立预后因素
Weiru Liang,Chenmeng Liu,Jingliao Zhang et al.
Weiru Liang et al.
Juvenile myelomonocytic leukemia (JMML) is a disorder characterized by the simultaneous presence of myeloproliferative and myelodysplastic features, primarily affecting infants and young children. Due to the heterogeneous genetic background...
Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia [0.03%]
错误！：序贯治疗强化可改善Waldenstrom巨球蛋白血症患者的生存率
[This corrects the article DOI: 10.1097/BS9.0000000000000179.]. Copyright © 2024 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the ...
Published Erratum
Blood science (Baltimore, Md.). 2024 Mar 7;6(2):e00185. DOI:10.1097/BS9.0000000000000185 2024
Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease [0.03%]
泊马度胺可以改善CAR-T疗法对复发难治多发性骨髓瘤或B细胞白血病/淋巴瘤伴髓外病变的治疗效果
Jie Zhao,Hui Yang,Junnan Ge et al.
Jie Zhao et al.
Relapsed and refractory multiple myeloma (RRMM) and B-cell leukemia/lymphoma with extramedullary disease (EMD) have poor prognosis and high mortality, lack of effective therapeutic approaches. We reported for the first time that 6 patients ...
Predictive value of thyroid function in severe aplastic anemia patients treated with immunosuppressive therapy [0.03%]
免疫抑制治疗的重型再生障碍性贫血患者甲状腺功能的预测价值
Yilin Liu,Jiali Huo,Meili Ge et al.
Yilin Liu et al.
To explore the predictive value of thyroid function in severe aplastic anemia (SAA) patients treated with immunosuppressive therapy (IST), 149 SAA patients in our center were enrolled between February 2015 and June 2020 in this study. We as...
COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study [0.03%]
血液病干细胞移植后免疫功能低下患者中的 COVID-19：初步研究
Zilu Zhang,Jingtao Huang,Luxiang Wang et al.
Zilu Zhang et al.
Data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients at early stage of immune reconstitution after hematopoietic stem cell transplantation (HSCT) are limited. In the present study, we retrospectively in...
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia [0.03%]
序贯治疗改善Waldenstrom巨球蛋白血症患者的生存率
Ying Yu,Wenjie Xiong,Tingyu Wang et al.
Ying Yu et al.
Waldenstrom macroglobulinemia (WM) is a type of incurable, indolent B-cell lymphoma that is prone to relapse. Over time, treatment strategies have progressed from cytotoxic drugs to rituximab (R)- or bortezomib (V)-based regimens, and have ...
Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs) [0.03%]
EBV相关T/NK淋巴增殖性疾病（EBV-T/NK-LPD）中TNFRSF13B的新杂合突变
Xinyue Deng,Tong Ge,Kefeng Shen et al.
Xinyue Deng et al.